Patents by Inventor Susan EGAN

Susan EGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12325875
    Abstract: The present disclosure relates to the use of host cell protein biomarkers to assess disulfide bond reduction in compositions comprising a protein of interest. In some embodiments, the disclosure relates to methods of predicting the occurrence of disulfide bond reduction or low molecular weight protein species in compositions comprising a protein of interest, wherein the expression or activity level of at least one host cell protein is measured and provides a benchmark value associated with the occurrence of disulfide bond reduction or low molecular weight species of said protein of interest. In some embodiments, the disclosure relates to methods of producing a protein of interest, wherein host cells capable of producing the protein of interest are cultured, the expression or activity level of at least one host cell protein is measured, and downstream isolation of the protein of interest is informed by the host cell protein measurements.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: June 10, 2025
    Assignee: Bristol-Myers Squibb Company
    Inventors: Anthony Joseph Cura, Xuankuo Xu, Zhengjian Li, Sanchayita Ghose, Susan Egan
  • Publication number: 20210010055
    Abstract: The present disclosure relates to the use of host cell protein biomarkers to assess disulfide bond reduction in compositions comprising a protein of interest. In some embodiments, the disclosure relates to methods of predicting the occurrence of disulfide bond reduction or low molecular weight protein species in compositions comprising a protein of interest, wherein the expression or activity level of at least one host cell protein is measured and provides a benchmark value associated with the occurrence of disulfide bond reduction or low molecular weight species of said protein of interest. In some embodiments, the disclosure relates to methods of producing a protein of interest, wherein host cells capable of producing the protein of interest are cultured, the expression or activity level of at least one host cell protein is measured, and downstream isolation of the protein of interest is informed by the host cell protein measurements.
    Type: Application
    Filed: March 15, 2019
    Publication date: January 14, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Anthony Joseph CURA, Xuankuo XU, Zhengjian LI, Sanchayita GHOSE, Susan EGAN